「4月迎」の検索結果
397件：1～5件目を表示
-
公司简介 | 关于千寿 | 千寿制药株式会社
公司名称 千寿制药株式会社 总部 〒541-0048 大阪市中央区瓦町3-1-9 TEL：+81-6-6201-2512 FAX：+81-6-6226-0406 成立时间 1947年4月9日 资金总额 1,415,500,000日元 高级管理层 主席吉田 有宏 总裁吉田 周平 专务董事杉澤 剛 常务董事井坂 光良 沿革 销售额趋势与构成
http://www.senju.co.jp/chinese/about/outline.html -
Mytear ALPITATTO EXα | OTC Products, etc. | Products | SENJU Pharmaceutical
This medicine is recommended for people who have continuing allergy symptoms with inflammation. Category 2 OTC medicines Mytear® ALPITATTO EXα Works on unbearable eye itching due to pollens and other
https://www.senju.co.jp/english/products/apex.html -
MytearV | OTC Products, etc. | Products | SENJU Pharmaceutical
Category 2 OTC medicines Mytear® V Resolves redness of the eye and provides healthy and clear eyes. CHARACTERISTICS Compounded with "tetrahydrozoline hydrochloride", a component to relieve r
https://www.senju.co.jp/english/products/mytearv.html -
Management Policy | About Senju | SENJU Pharmaceutical
“Being a good company” is our management policy. As a company that aims to be reliable, necessary and valuable for society, we are committed to pursuing happiness for all people associated with Senju
https://www.senju.co.jp/english/about/philosophy.html -
お知らせ | 千寿製薬株式会社
August 20, 2026 Senju initiated Phase III Clinical Trials in Japan for "SJP-0049" for the treatment of Allergic Conjunctivitis（PDF） June 1, 2026 Launch of Distribution of 3in1Smart and SPM-7
https://www.senju.co.jp/english/news/